Assessment of extrapyramidal disorders.
作者信息
Marsden C D, Schachter M
出版信息
Br J Clin Pharmacol. 1981 Feb;11(2):129-51. doi: 10.1111/j.1365-2125.1981.tb01118.x.
Abstract
摘要
相似文献
1
Assessment of extrapyramidal disorders.
Br J Clin Pharmacol. 1981 Feb;11(2):129-51. doi: 10.1111/j.1365-2125.1981.tb01118.x.
2
Basal ganglia disease.
Lancet. 1982 Nov 20;2(8308):1141-7. doi: 10.1016/s0140-6736(82)92797-0.
3
The pathophysiology of movement disorders.
Neurol Clin. 1984 Aug;2(3):435-59.
4
Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders.
Neuroscience. 1987 Apr;21(1):1-40. doi: 10.1016/0306-4522(87)90322-8.
5
Transcranial magnetic stimulation in movement disorders.
Electroencephalogr Clin Neurophysiol Suppl. 1999;51:276-80.
6
Reflex recovery curves in extrapyramidal disorders.
Adv Neurol. 1976;14:285-96.
7
The pharmacology of extrapyramidal movement disorders.
Monogr Neural Sci. 1973;2:1-136.
8
Basal Ganglia dysfunctions in movement disorders: What can be learned from computational simulations.
Mov Disord. 2016 Nov;31(11):1591-1601. doi: 10.1002/mds.26719. Epub 2016 Jul 9.
9
Myoclonus and extrapyramidal diseases.
Neurophysiol Clin. 2006 Sep-Dec;36(5-6):319-25. doi: 10.1016/j.neucli.2006.11.003. Epub 2006 Dec 13.
10
引用本文的文献
1
Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring.
Clin Park Relat Disord. 2022 May 17;6:100145. doi: 10.1016/j.prdoa.2022.100145. eCollection 2022.
2
Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?
Neurol Sci. 2022 Jun;43(6):3641-3647. doi: 10.1007/s10072-021-05833-8. Epub 2022 Jan 19.
3
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.
Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.
4
How Many Dystonias? Clinical Evidence.
Front Neurol. 2017 Feb 3;8:18. doi: 10.3389/fneur.2017.00018. eCollection 2017.
5
Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.
J Huntingtons Dis. 2014;3(3):233-52. doi: 10.3233/JHD-140115.
6
Electrophysiologic assessments of involuntary movements: tremor and myoclonus.
J Mov Disord. 2009 May;2(1):14-7. doi: 10.14802/jmd.09004. Epub 2009 Apr 30.
7
Gait measures with a triaxial accelerometer among patients with neurological impairment.
Neurol Sci. 2013 Apr;34(4):435-40. doi: 10.1007/s10072-012-1017-x. Epub 2012 Mar 25.
8
Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment.
J Neural Transm (Vienna). 2012 Aug;119(8):963-80. doi: 10.1007/s00702-011-0762-y. Epub 2012 Jan 10.
9
Objective measurement of dyskinesia in Parkinson's disease using a force plate.
Mov Disord. 2010 Apr 15;25(5):602-8. doi: 10.1002/mds.22856.
10
A network-based system to improve care for schizophrenia: the Medical Informatics Network Tool (MINT).
J Am Med Inform Assoc. 2004 Sep-Oct;11(5):358-67. doi: 10.1197/jamia.M1492. Epub 2004 Jun 7.
本文引用的文献
1
On the coexistence of parkinsonism and tardive dyskinesia.
Dis Nerv Syst. 1974 Jul;35(7):324-6.
2
An assessment of therapy in Parkinson's disease.
AMA Arch Neurol Psychiatry. 1951 Apr;65(4):489-502. doi: 10.1001/archneurpsyc.1951.02320040079007.
3
Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.
AMA Arch Intern Med. 1951 Apr;87(4):477-516. doi: 10.1001/archinte.1951.03810040002001.
4
[Neurological complications of neuroleptic medication].
Rev Neurol (Paris). 1959 Jun;100:553-95.
5
Progression and prognosis in Parkinson's disease.
J Nerv Ment Dis. 1960 Jun;130:556-66. doi: 10.1097/00005053-196006000-00017.
6
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Bull Johns Hopkins Hosp. 1964 Dec;115:465-80.
7
A method for evaluating disability in patients with Parkinson's disease.
J Nerv Ment Dis. 1961 Aug;133:143-7. doi: 10.1097/00005053-196108000-00010.
8
Physical factors concerned with the stiffness of normal and diseased joints.
Bull Johns Hopkins Hosp. 1960 Apr;106:215-31.
9
Tremor studies in normals and in Parkinsonism.
Arch Neurol. 1961 Jan;4:66-82. doi: 10.1001/archneur.1961.00450070068008.
10
A preliminary report on the measurement of Parkinson's disease.
Neurology. 1960 Dec;10:1096-102. doi: 10.1212/wnl.10.12.1096.
Zotero 插件